Covista
Valuation each multiple against its own 5-year range
Vs. peers Education & Training Services
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Covista (CVSA) | 3.63B | 14.91 | 2.55 | 0.00% |
| New Oriental (EDU) | 7.90B | 15.95 | 1.86 | 2.35% |
| TAL Education (TAL) | 5.32B | 7.36 | 1.28 | 0.00% |
| Laureate Education (LAUR) | 4.35B | 11.92 | 3.75 | 0.00% |
| Stride (LRN) | 3.14B | 10.37 | 1.88 | 0.00% |
| Grand Canyon Education (LOPE) | 2.76B | 11.55 | 4.31 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 5.4% below Morningstar's fair value estimate.
Fair value
Covista Inc earns a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 3% premium over our quantitative fair value estimate of $115.02 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.
The firm's unfavorable dividend structure decreases our valuation estimate. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. For example, the firm's forward dividend yield of 0% ranks in the bottom 30% compared with peers globally. This could imply a planned dividend cut or relatively high share price, which contributes to our view that shares are expensive.
Alternatively, the company's profitability is reassuring. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 7.9%, a core component of profitability, sits in the top 30% globally. This suggests that it is generating substantial earnings relative to its share price, which, despite our unfavorable price/fair value ratio, is a positive attribute.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Covista discussion 0 comments